Loqtorzi (toripalimab)

pCPA File Number: 23509

Negotiation Status:

Under consideration for negotiation

Indication(s):

In combination with cisplatin and gemcitabine, for the first-line treatment of adults with metastatic or with recurrent, locally advanced nasopharyngeal carcinoma (NPC).

Sponsor/Manufacturer:

Apotex Inc.

CDA-AMC Project Number:

PC0421-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable